22.692 articles found

A comparison of LEDD and motor scores following STN-DBS treatment in patient with young onset vs. late onset Parkinson's disease.

Park YS, Kim HY, Chang WS, Lee PH, Sohn YH, Chang JW.

Neuromodulation · 2010-10-01

DOI: 10.1111/j.1525-1403.2009.00273.xPMID: 21992878

The relationship between depression and regional cerebral blood flow in Parkinson's disease and the effect of selegiline treatment.

Imamura K, Okayasu N, Nagatsu T.

Acta Neurol Scand · 2010-09-29

DOI: 10.1111/j.1600-0404.2010.01443.xPMID: 20880269

Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap.

Calabresi P, Di Filippo M, Ghiglieri V, Tambasco N, Picconi B.

Lancet Neurol · 2010-09-27

DOI: 10.1016/s1474-4422(10)70218-0PMID: 20880751

EXO-S-MECAMYLAMINE FORMULATION AND USE IN TREATMENT

SHYTLE DOUGLAS, SANBERG PAUL, NEWMAN MARY, SILVER ARCHIE A.

· 2010-09-21

Therapeutic Agents Useful for Treating Pain

SUN QUN, WEN XIN.

· 2010-09-21

Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases

CASTILLO GERARDO M, CHOI PAULA, SNOW ALAN D.

· 2010-09-21

Effects of piclozotan (SUN N4057), a partial serotonin 1A receptor agonist, on motor complications induced by repeated administration of levodopa in parkinsonian rats.

Tani Y, Ogata A, Koyama M, Inoue T.

Eur J Pharmacol · 2010-09-19

DOI: 10.1016/j.ejphar.2010.09.013PMID: 20858480

Mitochondrial therapy for Parkinson's disease: neuroprotective pharmaconutrition may be disease-modifying.

Kones R.

Clin Pharmacol · 2010-09-17

DOI: 10.2147/cpaa.s12082PMID: 22291504

Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy.

Lewis TB, Glasgow JN, Glandon AM, Curiel DT, Standaert DG.

PLoS One · 2010-09-17

DOI: 10.1371/journal.pone.0012672PMID: 20862245

Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects.

Mure H, Hirano S, Tang CC, Isaias IU, Antonini A, Ma Y, Dhawan V, Eidelberg D.

Neuroimage · 2010-09-17

DOI: 10.1016/j.neuroimage.2010.09.028PMID: 20851193

Effect of controlled-release levodopa on the microstructure of sleep in Parkinson's disease.

Wailke S, Herzog J, Witt K, Deuschl G, Volkmann J.

Eur J Neurol · 2010-09-17

DOI: 10.1111/j.1468-1331.2010.03213.xPMID: 20849470

[Non-dopaminergic treatments for Parkinson's disease].

Derkinderen P.

Rev Neurol (Paris) · 2010-09-15

DOI: 10.1016/j.neurol.2010.08.002PMID: 20832090